RLMD · Relmada Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| TRAVERSA SERGIO Chief Executive Officer | ▲ Buy | Open Market | 1,500,000 Shares held | 9/10/2026 | View profile |
| Shenouda Maged Chief Financial Officer | ▲ Buy | Open Market | 1,000,000 Shares held | 9/10/2026 | View profile |
| Kelly Paul Edward Director | ▲ Buy | Open Market | 502,295 Shares held | 11/5/2025 | View profile |
| Ence Chuck CA and CO | ▲ Buy | Open Market | 403,931 Shares held | 11/5/2025 | View profile |
| O'Gorman Cedric Chief Medical Officer | ▲ Buy | Open Market | 10,121 Shares held | 5/23/2023 | View profile |
| Charles J. Casamento Director | ▼ Sell | Gift | 0 Shares held | 10/22/2024 | View profile |
Transaction History
| Shenouda Maged | ▲ Buy | Open Market | 79,800 | $339K | 9/10/2026 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 100,000 | $410K | 9/10/2026 |
| Shenouda Maged | ▲ Buy | Open Market | 120,200 | $505K | 9/9/2026 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 100,000 | $418K | 9/9/2026 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 27,500 | $113K | 12/15/2025 |
| Shenouda Maged | ▲ Buy | Open Market | 11,665 | $48K | 12/15/2025 |
| Shenouda Maged | ▲ Buy | Open Market | 500,000 | $1.1M | 11/5/2025 |
| Ence Chuck | ▲ Buy | Open Market | 136,000 | $299K | 11/5/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 272,500 | $600K | 11/5/2025 |
| Kelly Paul Edward | ▲ Buy | Open Market | 90,000 | $198K | 11/5/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 55,976 | $41K | 8/28/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 129,455 | $87K | 8/27/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 80,545 | $50K | 8/26/2025 |
| Shenouda Maged | ▲ Buy | Open Market | 60,000 | $31K | 5/20/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 147,686 | $82K | 5/20/2025 |
| Shenouda Maged | ▲ Buy | Open Market | 90,000 | $44K | 5/19/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 30,000 | $15K | 5/19/2025 |
| Kelly Paul Edward | ▲ Buy | Open Market | 200,000 | $86K | 5/16/2025 |
| Shenouda Maged | ▲ Buy | Open Market | 50,000 | $22K | 5/16/2025 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 172,314 | $77K | 5/16/2025 |
| Ence Chuck | ▲ Buy | Open Market | 228,961 | $103K | 5/16/2025 |
| Charles J. Casamento | ▼ Sell | Gift | 13,000 | $0 | 10/22/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 51,407 | $154K | 9/11/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 24,120 | $71K | 9/11/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 33,014 | $91K | 9/10/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 21,118 | $58K | 9/10/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 55,579 | $151K | 9/9/2024 |
| Charles J. Casamento | ▲ Buy | Open Market | 13,000 | $33K | 9/9/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 8,194 | $21K | 9/9/2024 |
| Kelly Paul Edward | ▲ Buy | Open Market | 25,000 | $65K | 9/9/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 27,460 | $110K | 1/31/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 6,875 | $28K | 1/31/2024 |
| Ence Chuck | ▲ Buy | Open Market | 13,670 | $55K | 1/31/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 40,999 | $160K | 1/30/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 15,000 | $58K | 1/30/2024 |
| Ence Chuck | ▲ Buy | Open Market | 14,500 | $56K | 1/30/2024 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 31,541 | $117K | 1/29/2024 |
| Shenouda Maged | ▲ Buy | Open Market | 10,800 | $39K | 1/29/2024 |
| Ence Chuck | ▲ Buy | Open Market | 10,800 | $39K | 1/29/2024 |
| O'Gorman Cedric | ▲ Buy | Open Market | 10,000 | $32K | 5/23/2023 |
| TRAVERSA SERGIO | ▲ Buy | Open Market | 55,250 | $116K | 12/8/2022 |
| TRAVERSA SERGIO | ▲ Buy | Option Exercise | 13,755 | $220K | 7/1/2022 |
| TRAVERSA SERGIO | ▼ Sell | Open Market | 839 | $16K | 7/1/2022 |
| TRAVERSA SERGIO | ▼ Sell | Open Market | 8,848 | $163K | 7/1/2022 |
| TRAVERSA SERGIO | ▼ Sell | Open Market | 4,068 | $75K | 7/1/2022 |
| TRAVERSA SERGIO | ▼ Sell | Open Market | 10,698 | $203K | 6/30/2022 |
| TRAVERSA SERGIO | ▲ Buy | Option Exercise | 16,012 | $256K | 6/30/2022 |
| TRAVERSA SERGIO | ▼ Sell | Open Market | 5,314 | $103K | 6/30/2022 |
| Kelly Paul Edward | ▲ Buy | Option Exercise | 10,000 | $32K | 4/4/2022 |
| Kelly Paul Edward | ▼ Sell | Open Market | 10,000 | $300K | 4/4/2022 |
| Charles J. Casamento | ▲ Buy | Option Exercise | 19,800 | $64K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 |
| Kelly Paul Edward | ▲ Buy | Option Exercise | 20,000 | $65K | 1/3/2022 |
| Charles J. Casamento | ▲ Buy | Option Exercise | 10,000 | $46K | 9/22/2021 |
| Charles J. Casamento | ▼ Sell | Open Market | 1,900 | $55K | 9/22/2021 |
| Charles J. Casamento | ▼ Sell | Open Market | 3,300 | $96K | 9/22/2021 |
| Charles J. Casamento | ▼ Sell | Open Market | 1,400 | $41K | 9/22/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Relmada Releases Q2 2026 Earnings Call Transcript
Relmada Therapeutics posted the full transcript of its Q2 2026 earnings call. The discussion covered the company’s financial performance for the quarter, updated guidance, and strategic priorities. Investors can review the transcript for details on revenue, expenses, and future outlook. The release provides a comprehensive view of the company’s recent results.
Relmada Releases Q2 2026 Earnings Call Transcript. Relmada Therapeutics posted the full transcript of its Q2 2026 earnings call. The discussion covered the company’s financial performance for the quarter, updated guidance, and strategic priorities. Investors can review the transcript for details on revenue, expenses, and future outlook. The release provides a comprehensive view of the company’s recent results.